HCC Management: From Guidelines to Clinical Practice

Golden Gate A & B
San Francisco Marriott
San Francisco, California


Thank you for your interest in this live program. Registration is closed, as the current schedule has been completed. Please email info@clinicaloptions.com for more information.

This independent satellite symposium will provide clinicians with updated information on clinical practice guidelines, practical therapeutic applications of targeted agents, and ongoing research to expand the treatment armamentarium for the treatment of patients with hepatocellular carcinoma.


Presented for attendees of the 59th AASLD Annual Meeting. This is not an official function/event of the American Association for the Study of Liver Diseases.

Program Director

Jordi Bruix, MD

Associate Professor of Medicine
University of Barcelona
Head, Barcelona Clinic-Liver Cancer Group
Liver Unit
Hospital ClĂ­nico of Barcelona
Barcelona, Spain


Faculty

Adrian M. Di Bisceglie, MD, FACP

Professor of Internal Medicine
Chairman

Department of Internal Medicine
Saint Louis University School of Medicine
Chief, Hepatology
Division of Gastroenterology and Hepatology
Saint Louis University Hospital
St Louis, Missouri


Riccardo Lencioni, MD

Medical Director, Division of Diagnostic and Interventional Radiology
Department of Oncology, Transplants, and Advanced Technologies in Medicine
University of Pisa School of Medicine
Pisa, Italy

 


Alan P. Venook, MD

Professor of Clinical Medicine
Department of Hematology and Oncology
Division of Medical Oncology
University of California, San Francisco
San Francisco, California


/upload/global/providers/pim_110.gif Jointly sponsored by Postgraduate Institute for Medicine and Clinical Care Options, LLC


Supported by an educational grant from
placeholder for supporter logos

There are no fees to participate in this educational activity.